Reticulocyte Count
Haematology marker
Reticulocytes
Reticulocyte Count
Immature red blood cells released from bone marrow. The absolute count is the most reliable indicator of bone marrow erythropoietic activity.
PED Notes
AAS stimulate erythropoiesis via increased EPO production, suppressed hepcidin, and direct bone marrow stimulation — reticulocyte counts are typically elevated on cycle. Boldenone (EQ) has particularly marked erythropoietic effects. After blood donation (common for managing high haematocrit), reticulocytes spike within 3-6 days and normalise by 9-12 days. EPO use produces dramatic elevations — counts doubling from baseline is characteristic.
When elevated (>100 x10^9/L — active erythropoiesis):
Elevated reticulocytes in an AAS user confirm the bone marrow is actively producing red cells:
- Check haemoglobin and haematocrit — if also elevated (Hb >180 g/L, HCT >0.52), consider blood donation
- If on Boldenone (EQ) — consider dose reduction if erythrocytosis is problematic
- Monitor iron studies — accelerated erythropoiesis depletes iron rapidly. Supplement if ferritin drops below 50 ug/L
- Hydration — 3-4L water/day to reduce blood viscosity
When low (<20 x10^9/L — inadequate bone marrow response):
Low reticulocytes on AAS is paradoxical and concerning:
- Iron deficiency — most likely cause from chronic blood donation. Check ferritin. Supplement with Iron Bisglycinate 25-50mg/day with Vitamin C 500mg
- B12 or Folate deficiency — required for DNA synthesis in erythroid precursors. Methylcobalamin 1000mcg/day, Methylfolate 800mcg/day
- Bone marrow suppression — rare but possible with hepatotoxic oral AAS at high doses
Post-blood donation monitoring:
- Reticulocytes peak 3-6 days after donation, normalise by 9-12 days
- If reticulocytes do NOT rise after donation, suspect iron deficiency limiting the marrow response
References:
- Bachman, E., Travison, T. G., Basaria, S., et al. (2014). Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin. The Journals of Gerontology: Series A, 69(6), 725-735. DOI: 10.1093/gerona/glt154
- Heiland, C. E., Schickel, Y., Lehtihet, M., Borjesson, A., & Ekstrom, L. (2023). Supra-physiological doses of anabolic androgenic steroids impact erythropoietin and blood parameters. Drug Testing and Analysis, 15, 599-604. DOI: 10.1002/dta.3452
- Goodnough, L. T., Nemeth, E., & Ganz, T. (2010). Detection, evaluation, and management of iron-restricted erythropoiesis. Blood, 116(23), 4754-4761. DOI: 10.1182/blood-2010-05-286260
History Chart
Reading History
Frequently Asked Questions
Reference Ranges
Standard Range
VitalMetrics Range